Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 19402064.
- Also identified by DOI 10.1002/cncr.24229 and PMC identifier 2892290.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.
Medical subject headings
- Carcinoma, Renal Cell
- Kidney Neoplasms